This observational study is looking at how psychoeducation works for people with depression in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This observational study is following people with major depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a digital support tool can help people with Subclinical Depressive Symptoms. Participants take part in a digital support tool and complete follow-up assessments.
uk) can help people with Recurrent depression, Mental and Behavioural Disorders, or Depressive episode. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether This is a multicenter, three-arm, cluster randomized controlled trial can help people with Perinatal depression or Mental and Behavioural Disorders. Participants take part in This is a multicenter, three-arm, cluster randomized controlled trial and complete follow-up assessments.
This study is comparing Psilocybin and Psilocyn with placebo for people with depression. Participants receive Psilocybin and Psilocyn or placebo and complete study visits and assessments.
In Foz do Iguaçu
Why is this study shown?
This study is directly about Depression.
DepressionDrugA study involving a medication or substance.From 25 Years to 65 Years
This study is looking at also assess whether psilocybin may improve quality of life in those individuals for people with Depressive Symptoms, Depression, Alzheimer Disease, or Mild Cognitive Impairment. Participants receive a study treatment and complete follow-up visits and assessments.
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
This study is looking at a support or therapy approach for people with Depression, Mental and Behavioural Disorders, or Recurrent depression, unspecified. Participants take part in the program or support approach and complete follow-up assessments.
This study is looking at care and outcomes for people with depression. Taking part may give some people access to 8 week treatment with citalopram 20 - 40 mg, citalopram pharmacoMRI, but direct benefit is not guaranteed.
This study is looking at whether All participants receive the same study drug can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.